Value proposition

First-in-human data to accelerate drug development

Genoskin is a pioneering contract research organization that leverages ethically sourced human skin to accelerate the development of biotherapies, vaccines, medical devices, and cosmetics. By integrating advanced technologies like transcriptomics, spatial biology, and bioinformatics with our ex vivo human skin models, we offer a robust platform for predicting compound efficacy and safety before human trials. Our models provide unparalleled insights into substance interactions, absorption, irritation, and overall skin response, reducing time-to-market and minimizing development risks. Committed to ethical research, we replace animal testing with human-relevant data, driving innovation in the biomedical, cosmetics, and skincare products industry.

Skin explant, Vaccine development, Cosmetics testing , Mast cells , Contract research organization (CRO), Medical devices testing , Toxicity testing , Injection site reactions, Live human tissue, Preclinical drug development , Early-phase development, Beauty products testing, Human skin models, Ex vivo skin models , Transcriptomic analysis, Preclinical studies, Nonclinical testing , and Biologics testing